Careers

Moderna VP and regulatory expert moves to private practice
2 February 2026   The third European life sciences hire in recent months brings in-house regulatory expertise from Moderna in Munich.

More News

16 January 2026   The team, known for pharmaceutical and biotechnology patent litigation—including Hatch-Waxman and BPCIA disputes—as well as trade secret and licensing matters, joins a rival US firm.
14 January 2026   A high-profile departure from the USPTO sees a senior appellate expert move into private practice as demand increases in the firm's life sciences IP practice.
14 January 2026   The US firm has recruited a European patent attorney with three decades of experience to build its patent prosecution offering across the continent.
12 January 2026   An experienced Ex-Hoffmann Eitle litigator, who worked on Sanofi v Amgen, joins the firm's growing UPC team in Munich, Germany.
9 January 2026   Simon Wright says he will focus on engagement with in-house and SME members, as well as support the UK rejoining the UPC and more as he takes the reins at the Chartered Institute of Patent Attorneys.
7 January 2026   A Brussels-based partner, specialising in pharmaceuticals and biologics, jumps ship as a competitor firm continues to build out its EU healthcare regulatory bench.
5 January 2026   The firm brings in a former Plesner director and Novo Nordisk in-house counsel with regulatory and compliance expertise.
More news